[Case Study] Koji Masuda and Kenji Ikeda “TDM Is Not Only for Safety, but for Ensuring E ...>>
[Case Study] Keisuke Kagami and Mitsuru Sugawara “Thrombocytopenia Can be Avoided By Mon ...>>
[Case Study] Keisuke Kagami and Mitsuru Sugawara “Concomitant piperacillin-tazobactam an ...>>
[Event Report] The 101st HGPI Seminar Looking Back at the History of Infectious Diseases ...>>
[In the Media] “Faster Response to Antimicrobial Resistant Bacteria” (The Nikkei Persona ...>>
[Event Report] The Third Meeting of Working Group 3 Under the Sub-committee on AMR of th ...>>
[Case Study] Akari Shigemi “The importance of proper antimicrobial use for MRSA infectio ...>>


![[Lived Experiences] Ms. Sachiko Ito – Non-Tuberculosis Mycobacterial Lung Disease (March 18, 2022)](https://hgpi.org/en/wp-content/uploads/sites/2/amr-case07-top_ENG.jpg)
![[Activity Report] Submission of recommendations to Public Comment on the “Interim Report of the Global Health Strategy in Japan Toward the 2030 Sustainable Development Goals (SDGs)” (February 25, 2022)](https://hgpi.org/en/wp-content/uploads/sites/2/amr-31-top_JPN.jpg)
![[Event Report] FY2022 AMR Alliance Japan Planning Meeting (December 6, 2021)](https://hgpi.org/en/wp-content/uploads/sites/2/AMRalliance-logo-11-16.jpg)
![[Publication Report] Incentivizing Resilience: Accelerating Efforts to Promote the Research and Development Needed to Save the World from the Next Pandemic (December 2, 2021)](https://hgpi.org/en/wp-content/uploads/sites/2/Incentivizing-Resilience-Report-top.jpg)
![[Event Report] Investing in the Future: The Role of Investors in Saving the World from AMR (September 8, 2021)](https://hgpi.org/en/wp-content/uploads/sites/2/AMRalliance-logo-11-14.jpg)
